Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL173379 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| Cyclooctane SCHEMBL11038481 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL13468315 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL2761107 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL25378505 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL1542881 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| Cyclohexane SCHEMBL23142614 | 1.00 | ALDH1A1 (0.33) | ALDH1A1 | |
| Cyclooctane SCHEMBL31262 | 1.00 | — | — | |
| Cyclohexane SCHEMBL2291099 | 1.00 | — | — | |
| SCHEMBL286862 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119708425-A | Polyurethane high-refraction optical material and preparation method and application thereof | 武汉尚赛光电科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| US-12246000-B2 | Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides | VILNIUS UNIVERSITY (LT) | 2025-03-11 | — | — | US | claimed |
| CN-119198974-B | Method for preparing pleshafu and method for determining potential ring-opening impurities in pleshafu | 北京元延医药科技股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-20250062407-A1 | ORGANIC ELECTROLYTE, AND SECONDARY BATTERY COMPRISING SAME | SAMSUNG SDI CO., LTD. (KR) | 2025-02-20 | — | — | US | claimed |
| CN-119390669-A | Method for promoting ion extraction based on molecular space configuration | 清华大学 | 2025-02-07 | — | — | CN | claimed |
| CN-119198974-A | Method for preparing pleshafu and method for determining potential ring-opening impurities in pleshafu | 北京元延医药科技股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| US-12176484-B2 | Organic electrolyte, and secondary battery comprising same | SAMSUNG SDI CO., LTD. (KR) | 2024-12-24 | — | — | US | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| CN-117894507-A | Curing type conductive paste for perovskite solar cell and preparation method and application thereof | 中国科学院化学研究所 | 2024-04-16 | — | — | CN | claimed |
| US-20240000736-A1 | INHIBITION OF PROTEIN AMYLOID AGGREGATION USING FLUORINATED BENZENESULFONAMIDES | VILNIUS UNIVERSITY (LT) | 2024-01-04 | — | — | US | claimed |
| WO-2012018160-A1 | SILICONE BASED WATER REPELLENT COATING COMPOSITION FOR MODIFYING THE SURFACE OF NON-POROUS SUBSTRATE | DNF CO.,LTD. (KR) | 2012-02-09 | — | — | WO | claimed |
| US-7759336-B2 | Nitrogen-containing heterocyclic compounds and medicinal use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-07-20 | — | — | US | claimed |
| US-20080102211-A1 | tetralin, p-menthane, p-cymene, alpha -pinene and 1,8-cineole mixtures, optionally used with aliphatic or alicyclic hydrocarbons, for edge bead removal after the formation of polysilazane coating films on substrates; excellent dissolving power and stability; nontoxic | MERCK PATENT GMBH (DE) | 2008-05-01 | — | — | US | claimed |
| EP-1325146-B1 | PROCESS FOR PREPARING OPTICALLY ACTIVE 4-HYDROXY-2-PYRROLIDINONE AND N-SUBSTITUTED 4-HYDROXY-2-PYRROLIDINONES BY ENZYMATIC HYDROXYLATION | EIDGENOESSICHE TECH HOCHSCHULE (CH) | 2005-12-14 | — | — | EP | claimed |
| US-20040009562-A1 | Process for preparing optically active 4-hydroxy-2-pyrrolidinone and n-substituted 4-hydroxy-2-pyrrolidinones by enzymatic hydroxylation | EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH (CH) | 2004-01-15 | — | — | US | claimed |
| EP-1325146-A2 | PROCESS FOR PREPARING OPTICALLY ACTIVE 4-HYDROXY-2-PYRROLIDINONE AND N-SUBSTITUTED 4-HYDROXY-2-PYRROLIDINONES BY ENZYMATIC HYDROXYLATION | Eidgenössiche Technische Hochschule Zürich (CH) | 2003-07-09 | — | — | EP | claimed |
| WO-2002031174-A2 | PROCESS FOR PREPARING OPTICALLY ACTIVE 4-HYDROXY-2-PYRROLIDINONE AND N-SUBSTITUTED 4-HYDROXY-2-PYRROLIDINONES BY ENZYMATIC HYDROXYLATION | EIDGENÖSSICHE TECHNISCHE HOCHSCHULE ZÜRICH (CH) | 2002-04-18 | — | — | WO | claimed |
| EP-1197561-A1 | Process for preparing optically active 4-hydroxy-2-pyrrolidinone and N-substituted 4-hydroxy-2-pyrrolidinones by enzymatic hydroxylation | Eidgenössische Technische Hochschule Zürich (CH) | 2002-04-17 | — | — | EP | claimed |
| EP-0863885-A2 | NOVEL MACROCYCLIC COMPOUNDS AS METALLOPROTEASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-09-16 | — | — | EP | claimed |
| WO-1997018207-A2 | NOVEL MACROCYCLIC COMPOUNDS AS METALLOPROTEASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-05-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080102211-A1 | tetralin, p-menthane, p-cymene, alpha -pinene and 1,8-cineole mixtures, optionally used with aliphatic or alicyclic hydrocarbons, for edge bead removal after the formation of polysilazane coating films on substrates; excellent dissolving power and stability; nontoxic | CCT8, PTMA, CCT7 | ALDH1A1 2610/4885 |
| US-20240000736-A1 | INHIBITION OF PROTEIN AMYLOID AGGREGATION USING FLUORINATED BENZENESULFONAMIDES | APP, APBA1, IAPP | ALDH1A1 3244/4885 |
| US-12246000-B2 | Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides | APP, APBA1, IAPP | ALDH1A1 3244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.